Literature DB >> 23474218

Anti-tuberculosis neolignans from Piper regnellii.

R B L Scodro1, C T A Pires, V S Carrara, C O T Lemos, L Cardozo-Filho, V A Souza, A G Corrêa, V L D Siqueira, M V C Lonardoni, R F Cardoso, D A G Cortez.   

Abstract

The present study determined the anti-Mycobacterium tuberculosis activities of supercritical CO2 extracts, neolignans eupomatenoid-5 (1), conocarpan (4) and eupomatenoid-3 (7) and their derivatives (2, 3, 5, 6, and 8) from Piper regnellii, as well as their cytotoxicities. The supercritical CO2 extract from leaves was purified by chromatographic methods, yielding compounds (1), (4) and (7), which were identified by (1)H NMR and comparison with literature data. Anti-M. tuberculosis activity (H37Rv and clinical isolates) was evaluated using a resazurin microtiter assay plate (REMA) to determine the MIC. The cytotoxicity assay was carried out in macrophages J774G.8 by sulforhodamine B colorimetric assay. The supercritical CO2 extracts from leaves and stems, and compound (4) showed activity against M. tuberculosis (MIC 15.6 μg/ml). Compound (1) showed the best activity (MIC 1.9 μg/ml), with good SI. Compounds (7) and (8) showed low activity against M. tuberculosis H37Rv. The derivative compounds did not show increased anti-M. tuberculosis activity. This is the first report, to our knowledge, to describe neolignans from P. regnellii with activity against M. tuberculosis, and compound (1) is a potential candidate for future antituberculosis drugs.
Copyright © 2013 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474218     DOI: 10.1016/j.phymed.2013.01.005

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  1 in total

1.  Anti-Mycobacterium tuberculosis activity and cytotoxicity of Calophyllum brasiliense Cambess (Clusiaceae).

Authors:  Claudia Terencio Agostinho Pires; Mislaine Adriana Brenzan; Regiane Bertin de Lima Scodro; Diógenes Aparício Garcia Cortez; Luciana Dias Ghiraldi Lopes; Vera Lucia Dias Siqueira; Rosilene Fressatti Cardoso
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-03-04       Impact factor: 2.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.